Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.

Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.

Scand J Rheumatol. 2019 Dec 5:1-7. doi: 10.1080/03009742.2019.1672782. [Epub ahead of print]

PMID:
31801390
2.

Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition.

Miyara M, Charuel JL, Mudumba S, Wu A, Ghillani-Dalbin P, Amoura Z, Burlingame RW, Musset L.

PLoS One. 2018 Aug 30;13(8):e0202736. doi: 10.1371/journal.pone.0202736. eCollection 2018.

3.

Photonic ring resonance is a versatile platform for performing multiplex immunoassays in real time.

Mudumba S, de Alba S, Romero R, Cherwien C, Wu A, Wang J, Gleeson MA, Iqbal M, Burlingame RW.

J Immunol Methods. 2017 Sep;448:34-43. doi: 10.1016/j.jim.2017.05.005. Epub 2017 May 17.

4.

Disability and quality-of-life are not influenced by the prevalence of autoantibodies in early rheumatoid arthritis patients--results of the Brasília Cohort.

Mota LM, Santos Neto LL, Burlingame RW, Ménard HA, Pereira IA, Carvalho JF, Laurindo IM.

Rev Bras Reumatol. 2012 Dec;52(6):824-9. English, Portuguese.

PMID:
23223694
5.

Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.

Swart A, Burlingame RW, Gürtler I, Mahler M.

Clin Chim Acta. 2012 Dec 24;414:266-72. doi: 10.1016/j.cca.2012.09.015. Epub 2012 Sep 25.

6.

IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.

Grönwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman GJ.

Clin Immunol. 2012 Mar;142(3):390-8. doi: 10.1016/j.clim.2012.01.002. Epub 2012 Jan 14.

7.

Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort.

da Mota LM, Dos Santos Neto LL, Oliveira AC, Pereira IA, Burlingame RW, Ménard HA, Laurindo IM.

Rheumatol Int. 2012 Dec;32(12):3937-43. doi: 10.1007/s00296-011-2261-8. Epub 2011 Dec 25.

PMID:
22198690
8.

Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.

Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.

Semin Arthritis Rheum. 2012 Jun;41(6):840-8. doi: 10.1016/j.semarthrit.2011.09.009. Epub 2011 Dec 15.

PMID:
22177108
9.

Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding.

Jacob RS, Silva CY, Powers JG, Schieke SM, Mendese G, Burlingame RW, Miller DD, Wolpowitz D, Graber E, Mahalingam M.

Am J Dermatopathol. 2012 Apr;34(2):208-13. doi: 10.1097/DAD.0b013e31821cc0bf.

PMID:
22094232
10.

Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.

Satoh M, Vazquez-Del Mercado M, Krzyszczak ME, Li Y, Ceribelli A, Burlingame RW, Webb TT, Sobel ES, Reeves WH, Chan EK.

Lupus. 2012 Jan;21(1):68-74. doi: 10.1177/0961203311422712. Epub 2011 Oct 24.

11.

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.

Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.

Lupus. 2011 Oct;20(12):1267-74. doi: 10.1177/0961203311411597. Epub 2011 Aug 3.

PMID:
21813587
12.

Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.

Ceribelli A, Krzyszczak ME, Li Y, Ross SJ, Chan JY, Chan EK, Burlingame RW, Webb TT, Bubb MR, Sobel ES, Reeves WH, Satoh M.

Arthritis Res Ther. 2011 Jul 22;13(4):R119. doi: 10.1186/ar3422.

13.

Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole.

Walsh NM, Green PJ, Burlingame RW, Pasternak S, Hanly JG.

J Cutan Pathol. 2010 Dec;37(12):1212-9. doi: 10.1111/j.1600-0560.2010.01613.x. Epub 2010 Aug 25.

PMID:
20738457
14.

'Actin-reactive' discriminated from 'non-actin-reactive' smooth muscle autoantibody by immunofluorescence reactivity with rat epithelial cell line.

Toh BH, Taylor R, Pollock W, Dearden S, Gill CC, Buchner C, Burlingame RW.

Pathology. 2010;42(5):463-9. doi: 10.3109/00313025.2010.493867.

PMID:
20632824
15.

Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.

Maes L, Blockmans D, Verschueren P, Westhovens R, De Beéck KO, Vermeersch P, Van den Bergh K, Burlingame RW, Mahler M, Bossuyt X.

Clin Chim Acta. 2010 Jul 4;411(13-14):965-71. doi: 10.1016/j.cca.2010.03.018. Epub 2010 Mar 25.

PMID:
20346932
16.

Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis.

Parker JC, Burlingame RW, Bunn CC.

J Autoimmune Dis. 2009 Mar 6;6:2. doi: 10.1186/1740-2557-6-2.

17.

Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.

Moura CG, Lima I, Barbosa L, Athanazio D, Reis E, Reis M, Burlingame RW, Santiago MB.

J Clin Lab Anal. 2009;23(1):19-23. doi: 10.1002/jcla.20280.

18.

[Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?].

Andreoli L, Pregnolato F, Burlingame RW, Fanelli V, Allegri F, Radice A, Corace C, Sinico RA, Tincani A, Meroni PL.

Reumatismo. 2008 Jul-Sep;60(3):185-91. Italian.

19.

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.

dos Anjos LM, Pereira IA, d 'Orsi E, Seaman AP, Burlingame RW, Morato EF.

Clin Rheumatol. 2009 Feb;28(2):153-8. doi: 10.1007/s10067-008-0999-5. Epub 2008 Sep 16.

PMID:
18795390
20.

Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value.

Gómez-Puerta JA, Burlingame RW, Cervera R.

Autoimmun Rev. 2008 Sep;7(8):606-11. doi: 10.1016/j.autrev.2008.06.005. Epub 2008 Jul 9. Review.

PMID:
18606252
21.

Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA.

Parker JC, Burlingame RW, Webb TT, Bunn CC.

Rheumatology (Oxford). 2008 Jul;47(7):976-9. doi: 10.1093/rheumatology/ken201. Epub 2008 May 22.

22.

Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?

Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, Tincani A.

J Autoimmun. 2008 Feb-Mar;30(1-2):51-7. doi: 10.1016/j.jaut.2007.11.004.

PMID:
18191541
23.

Multiplex assays to diagnose celiac disease.

Lochman I, Martis P, Burlingame RW, Lochmanová A.

Ann N Y Acad Sci. 2007 Aug;1109:330-7.

PMID:
17785322
24.

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ.

J Rheumatol. 2007 Jul;34(7):1528-34. Epub 2007 Jun 15.

PMID:
17610318
25.

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF.

Silveira IG, Burlingame RW, von Mühlen CA, Bender AL, Staub HL.

Clin Rheumatol. 2007 Nov;26(11):1883-9. Epub 2007 Apr 5.

PMID:
17410320
26.

Anti-chromatin (anti-nucleosome) antibodies.

Gómez-Puerta JA, Burlingame RW, Cervera R.

Lupus. 2006;15(7):408-11. Review.

PMID:
16898174
27.

Reactivity of IgG antibody with cyclic citrullinated peptide occurs through the F(ab)'2 part of the Ig molecule.

Burlingame RW.

J Rheumatol. 2005 May;32(5):964-5. No abstract available.

PMID:
15909375
28.

Anti-chromatin (anti-nucleosome) autoantibodies.

Burlingame RW, Cervera R.

Autoimmun Rev. 2002 Dec;1(6):321-8. Review.

PMID:
12848987
29.

Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Cervera R, Viñas O, Ramos-Casals M, Font J, García-Carrasco M, Sisó A, Ramírez F, Machuca Y, Vives J, Ingelmo M, Burlingame RW.

Ann Rheum Dis. 2003 May;62(5):431-4.

31.

The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

Burlingame RW, Volzer MA, Harris J, Du Clos TW.

J Immunol. 1996 Jun 15;156(12):4783-8.

PMID:
8648125
32.

Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice.

Duncan SR, Rubin RL, Burlingame RW, Sinclair SB, Pekny KW, Theofilopoulos AN.

Clin Immunol Immunopathol. 1996 May;79(2):171-81.

PMID:
8620623
33.
34.

C-reactive protein binds to Fc gamma RI in transfected COS cells.

Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW.

J Immunol. 1995 Aug 15;155(4):2185-93.

PMID:
7636267
35.

Expression and radiolabeling of human C-reactive protein in baculovirus-infected cell lines and Trichoplusia ni larvae.

Marnell L, Mold C, Volzer MA, Burlingame RW, Du Clos TW.

Protein Expr Purif. 1995 Aug;6(4):439-46.

PMID:
8527929
36.

IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.

Rubin RL, Burlingame RW, Arnott JE, Totoritis MC, McNally EM, Johnson AD.

J Immunol. 1995 Mar 1;154(5):2483-93.

PMID:
7868914
37.

Lupus susceptibility loci in New Zealand mice.

Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN.

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10168-72.

38.

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.

Burlingame RW, Boey ML, Starkebaum G, Rubin RL.

J Clin Invest. 1994 Jul;94(1):184-92.

39.

Antihistone antibodies in systemic lupus erythematosus: assay dependency and effects of ubiquitination and serum DNA.

Suzuki T, Burlingame RW, Casiano CA, Boey ML, Rubin RL.

J Rheumatol. 1994 Jun;21(6):1081-91.

PMID:
7932418
40.

Autoantibodies to chromatin components in juvenile rheumatoid arthritis.

Burlingame RW, Rubin RL, Rosenberg AM.

Arthritis Rheum. 1993 Jun;36(6):836-41.

PMID:
8507226
41.

Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen.

Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN.

J Clin Invest. 1993 Apr;91(4):1687-96.

42.

Antibodies in rabbits immunized with cationized IgG react with histones H3 and H4.

Suzuki T, Burlingame RW, Cavalot F, Andres G, Kashiwazaki S, Tan EM.

Arthritis Rheum. 1992 Oct;35(10):1218-26.

PMID:
1384512
43.
44.
45.

The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix.

Arents G, Burlingame RW, Wang BC, Love WE, Moudrianakis EN.

Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10148-52.

46.
47.

Analysis of the binding of C-reactive protein to chromatin subunits.

Du Clos TW, Marnell L, Zlock LR, Burlingame RW.

J Immunol. 1991 Feb 15;146(4):1220-5.

PMID:
1991964
48.

Drug-induced autoimmunity: a disorder at the interface between metabolism and immunity.

Rubin RL, Burlingame RW.

Biochem Soc Trans. 1991 Feb;19(1):153-9. Review. No abstract available.

PMID:
2037138
49.

Subnucleosome structures as substrates in enzyme-linked immunosorbent assays.

Burlingame RW, Rubin RL.

J Immunol Methods. 1990 Dec 5;134(2):187-99.

PMID:
1701469
50.

Crystallographic structure of the octamer histone core of the nucleosome.

Moudrianakis EN, Love WE, Burlingame RW.

Science. 1985 Sep 13;229(4718):1113. No abstract available.

PMID:
17753286

Supplemental Content

Loading ...
Support Center